Works matching IS 02683369 AND DT 2015 AND VI 50 AND IP 5

Results: 21

Related hematopoietic cell donor care: is there a role for unrelated donor registries?

Published in:

Bone Marrow Transplantation, 2015, v. 50, n. 5, p. 637, doi. 10.1038/bmt.2015.15

By:

Anthias, C;
van Walraven, S M;
Sørensen, B S;
de Faveri, G N;
Fechter, M;
Cornish, J;
Bacigalupo, A;
Müller, C;
Boo, M;
Shaw, B E

Publication type:

Article

Alternative donor transplant of benign primary hematologic disorders.

Published in:

Bone Marrow Transplantation, 2015, v. 50, n. 5, p. 619, doi. 10.1038/bmt.2015.1

By:

Tolar, J;
Sodani, P;
Symons, H

Publication type:

Article

A time to stop, a time to start: high-dose chemotherapy in overweight and obese patients.

Published in:

Bone Marrow Transplantation, 2015, v. 50, n. 5, p. 617, doi. 10.1038/bmt.2015.26

By:

Berger, N A

Publication type:

Article

Once-daily i.v. BU-based conditioning regimen before allogeneic hematopoietic SCT: a study of influence of GST gene polymorphisms on BU pharmacokinetics and clinical outcomes in Chinese patients.

Published in:

Bone Marrow Transplantation, 2015, v. 50, n. 5, p. 696, doi. 10.1038/bmt.2015.14

By:

Yin, J;
Xiao, Y;
Zheng, H;
Zhang, Y C

Publication type:

Article

Outcomes after autologous SCT in lymphoma patients grouped by weight.

Published in:

Bone Marrow Transplantation, 2015, v. 50, n. 5, p. 652, doi. 10.1038/bmt.2014.327

By:

Lau, J E;
Weber, C;
Earl, M;
Rybicki, L A;
Carlstrom, K D;
Wenzell, C M;
Hill, B T;
Majhail, N S;
Kalaycio, M

Publication type:

Article

Secondary malignancies following high dose therapy and autologous hematopoietic cell transplantation-systematic review and meta-analysis.

Published in:

Bone Marrow Transplantation, 2015, v. 50, n. 5, p. 706, doi. 10.1038/bmt.2014.325

By:

Vaxman, I;
Ram, R;
Gafter-Gvili, A;
Vidal, L;
Yeshurun, M;
Lahav, M;
Shpilberg, O

Publication type:

Article

Successful mobilization of PBSCs predicts favorable outcomes in multiple myeloma patients treated with novel agents and autologous transplantation.

Published in:

Bone Marrow Transplantation, 2015, v. 50, n. 5, p. 673, doi. 10.1038/bmt.2014.322

By:

Brioli, A;
Perrone, G;
Patriarca, F;
Pezzi, A;
Nobile, F;
Ballerini, F;
Motta, M R;
Ronconi, S;
Tacchetti, P;
Catalano, L;
Zannetti, B A;
Rizzi, S;
Volpe, S;
Zamagni, E;
Liberati, A M;
Mancuso, K;
Boccadoro, M;
Davies, F E;
Morgan, G J;
Palumbo, A

Publication type:

Article

Therapy-related ALL: cytogenetic features and hematopoietic cell transplantation outcome.

Published in:

Bone Marrow Transplantation, 2015, v. 50, n. 5, p. 746, doi. 10.1038/bmt.2015.8

By:

Aldoss, I;
Dagis, A;
Palmer, J;
Forman, S;
Pullarkat, V

Publication type:

Article

Haploidentical BMT and post-transplant Cy for severe aplastic anemia: a multicenter retrospective study.

Published in:

Bone Marrow Transplantation, 2015, v. 50, n. 5, p. 685, doi. 10.1038/bmt.2015.20

By:

Esteves, I;
Bonfim, C;
Pasquini, R;
Funke, V;
Pereira, N F;
Rocha, V;
Novis, Y;
Arrais, C;
Colturato, V;
de Souza, M P;
Torres, M;
Fernandes, J F;
Kerbauy, F R;
Ribeiro, A A F;
Santos, F P S;
Hamerschlak, N

Publication type:

Article

Utilization of stored autologous PBSCs to support second autologous transplantation in multiple myeloma patients in the era of novel agent therapy.

Published in:

Bone Marrow Transplantation, 2015, v. 50, n. 5, p. 663, doi. 10.1038/bmt.2015.13

By:

Phipps, C;
Linenberger, M;
Holmberg, L A;
Green, D;
Becker, P;
Connelly-Smith, L;
Klippel, Z;
Burwick, N;
Gopal, A;
Bensinger, W I;
Libby, E

Publication type:

Article

5-Azacytidine and DLI can induce long-term remissions in AML patients relapsed after allograft.

Published in:

Bone Marrow Transplantation, 2015, v. 50, n. 5, p. 690, doi. 10.1038/bmt.2015.10

By:

Steinmann, J;
Bertz, H;
Wäsch, R;
Marks, R;
Zeiser, R;
Bogatyreva, L;
Finke, J;
Lübbert, M

Publication type:

Article

Clinical significance of pretransplant serum ferritin on the outcome of allogeneic hematopoietic SCT: a prospective cohort study by the Kanto Study Group for Cell Therapy.

Published in:

Bone Marrow Transplantation, 2015, v. 50, n. 5, p. 727, doi. 10.1038/bmt.2015.17

By:

Tanaka, M;
Kanamori, H;
Matsumoto, K;
Tachibana, T;
Numata, A;
Ohashi, K;
Kobayashi, T;
Nakaseko, C;
Kanda, Y;
Yamazaki, E;
Fujisawa, S;
Ooi, J;
Sakura, T;
Aotsuka, N;
Onoda, M;
Machida, S;
Kato, J;
Usuki, K;
Watanabe, R;
Taguchi, J

Publication type:

Article

Markers of coagulation activation and acute kidney injury in patients after hematopoietic cell transplantation.

Published in:

Bone Marrow Transplantation, 2015, v. 50, n. 5, p. 715, doi. 10.1038/bmt.2015.2

By:

Hingorani, S R;
Seidel, K;
Pao, E;
Lawler, R;
McDonald, G B

Publication type:

Article

A multigene array for measurable residual disease detection in AML patients undergoing SCT.

Published in:

Bone Marrow Transplantation, 2015, v. 50, n. 5, p. 642, doi. 10.1038/bmt.2014.326

By:

Goswami, M;
McGowan, K S;
Lu, K;
Jain, N;
Candia, J;
Hensel, N F;
Tang, J;
Calvo, K R;
Battiwalla, M;
Barrett, A J;
Hourigan, C S

Publication type:

Article

Allo-SCT for myelofibrosis: reversing the chronic phase in the JAK inhibitor era?

Published in:

Bone Marrow Transplantation, 2015, v. 50, n. 5, p. 628, doi. 10.1038/bmt.2014.323

By:

Tamari, R;
Mughal, T I;
Rondelli, D;
Hasserjian, R;
Gupta, V;
Odenike, O;
Fauble, V;
Finazzi, G;
Pane, F;
Mascarenhas, J;
Prchal, J;
Giralt, S;
Hoffman, R

Publication type:

Article

Risk model incorporating donor IL6 and IFNG genotype and gastrointestinal GVHD can discriminate patients at high risk of steroid refractory acute GVHD.

Published in:

Bone Marrow Transplantation, 2015, v. 50, n. 5, p. 734, doi. 10.1038/bmt.2015.19

By:

Alam, N;
Xu, W;
Atenafu, E G;
Uhm, J;
Seftel, M;
Gupta, V;
Kuruvilla, J;
Lipton, J H;
Messner, H A;
Kim, D D H

Publication type:

Article

Sequential therapy combining clofarabine and T-cell-replete HLA-haploidentical haematopoietic SCT is feasible and shows efficacy in the treatment of refractory or relapsed aggressive lymphoma.

Published in:

Bone Marrow Transplantation, 2015, v. 50, n. 5, p. 679, doi. 10.1038/bmt.2014.328

By:

Zoellner, A-K;
Fritsch, S;
Prevalsek, D;
Engel, N;
Hubmann, M;
Reibke, R;
Rieger, C T;
Hellmuth, J C;
Haas, M;
Mumm, F;
Herold, T;
Ledderose, G;
Hiddemann, W;
Dreyling, M;
Hausmann, A;
Tischer, J

Publication type:

Article

Subsequent malignant neoplasms in pediatric cancer patients treated with and without hematopoietic SCT.

Published in:

Bone Marrow Transplantation, 2015, v. 50, n. 5, p. 721, doi. 10.1038/bmt.2015.4

By:

Pole, J D;
Darmawikarta, D;
Gassas, A;
Ali, M;
Egler, M;
Greenberg, M L;
Doyle, J;
Nathan, P C;
Schechter, T

Publication type:

Article

High-dose therapy with auto-SCT is feasible in high-risk cardiac amyloidosis.

Published in:

Bone Marrow Transplantation, 2015, v. 50, n. 5, p. 668, doi. 10.1038/bmt.2015.21

By:

Kongtim, P;
Qazilbash, M H;
Shah, J J;
Hamdi, A;
Shah, N;
Bashir, Q;
Wang, M;
Champlin, R;
Manasanch, E E;
Weber, D;
Orlowski, R Z;
Parmar, S

Publication type:

Article

Kinetics of peripheral blood chimerism for surveillance of patients with leukemia and chronic myeloid malignancies after reduced-intensity conditioning allogeneic hematopoietic SCT.

Published in:

Bone Marrow Transplantation, 2015, v. 50, n. 5, p. 743, doi. 10.1038/bmt.2015.3

By:

Eggimann, L;
Girsberger, S;
Halter, J;
Gerull, S;
Tichelli, A;
Baldomero, H;
Heim, D;
Passweg, J;
Rovó, A

Publication type:

Article

Allogeneic hematopoietic SCT in multiple myeloma: long-term results from a single institution.

Published in:

Bone Marrow Transplantation, 2015, v. 50, n. 5, p. 658, doi. 10.1038/bmt.2014.320

By:

Rosiñol, L;
Jiménez, R;
Rovira, M;
Martínez, C;
Fernández-Avilés, F;
Marín, P;
Suárez-Lledó, M;
Gutiérrez-García, G;
Fernández de Larrea, C;
Carreras, E;
Urbano-Ispizua, A;
Bladé, J

Publication type:

Article